CSIMarket
 


Axcella Health Inc   (AXLA)
Other Ticker:  
 

Axcella Health Inc 's Tangible Leverage Ratio

AXLA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


In Spite of the repayements of liabilities of -18.64%, in I Quarter 2023 ,Tangible Leverage Ratio deteriorated to 14.1 reached a new all-time high.

Within Biotechnology & Pharmaceuticals industry in the first quarter 2023, 193 other companies have achieved lower Tangible Leverage Ratio than Axcella Health Inc in the I Quarter 2023. While Tangible Leverage Ratio total ranking has improved so far in the first quarter 2023 to 3219, from total ranking in the forth quarter 2022 at 3503 .

Explain Tangible Leverage Ratio?
What is AXLA Market Share?
What are AXLA´s Total Liabilities?


AXLA Tangible Leverage Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Tangible Equity Change -97.57 % -81.08 % - -80.66 % -51.52 %
Y / Y Total Liabilities Change -70.92 % -64.72 % 12.31 % 13.16 % 7.4 %
Tangible Leverage Ratio MRQ 14.1 3.03 - 4.06 1.18
AXLA's Total Ranking # 3219 # 3503 # 0 # 3452 # 1889
Seq. Tangible Equity Change -82.54 % - - -68.89 % 35.82 %
Seq. Total Liabilities Change -18.64 % -66.26 % -1.16 % 7.21 % -1.31 %



Tangible Leverage Ratio first quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 194
Healthcare Sector # 820
Overall Market # 3219


Tangible Leverage Ratio Statistics
High Average Low
14.1 1.95 0.34
(Mar 31 2023)   (Jun 30 2020)




Financial Statements
Axcella Health Inc 's Tangible Equity $ 1 Millions Visit AXLA's Balance sheet
Axcella Health Inc 's Total Liabilities $ 10 Millions Visit AXLA's Balance sheet
Source of AXLA's Sales Visit AXLA's Sales by Geography


Cumulative Axcella Health Inc 's Tangible Leverage Ratio

AXLA's Tangible Leverage Ratio for the trailling 12 Months

AXLA Tangible Leverage Ratio

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Tangible Equity TTM Growth -97.57 % -81.08 % - -80.66 % -51.52 %
Y / Y Total Liabilities TTM Growth -70.92 % -64.72 % 12.31 % 13.16 % 7.4 %
Tangible Leverage Ratio TTM 14.77 3.44 2.72 1.47 1.02
Total Ranking TTM # 336 # 262 # 17 # 8 # 2003
Seq. Tangible Equity TTM Growth -82.54 % - - -68.89 % 35.82 %
Seq. Total Liabilities TTM Growth -18.64 % -66.26 % -1.16 % 7.21 % -1.31 %


On the trailing twelve months basis Despite of the repayements of liabilities of -18.64% in the trailing twelve months ending in I Quarter 2023, Tangible Leverage Ratio improved to 14.77, above Axcella Health Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 34, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Axcella Health Inc . While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2023, compared to the prior period, from 262 to 336.

Explain Tangible Leverage Ratio?
What is AXLA Market Share?
What are AXLA´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 35
Healthcare Sector # 186
Within the Market # 336


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
15.94 2.64 0.41
(Mar 31 2023)   (Mar 31 2021)




Companies with similar Tangible Leverage Ratio in the quarter ending Mar 31 2023, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioMar 31 2023 MRQ Total LiabilitiesMar 31 2023 MRQ Tangible Equity
Nanostring Technologies Inc   22.53 $ 306.795  Millions$ 13.620  Millions
Inhibrx Inc   15.45 $ 233.847  Millions$ 15.133  Millions
Enzon Pharmaceuticals inc   14.13 $ 43.422  Millions$ 3.073  Millions
Axcella Health Inc   14.10 $ 10.253  Millions$ 0.727  Millions
Armata Pharmaceuticals Inc   8.42 $ 73.228  Millions$ 8.701  Millions
Coeptis Therapeutics Holdings Inc   5.97 $ 5.050  Millions$ 0.846  Millions
Champions Oncology Inc   5.18 $ 22.284  Millions$ 4.301  Millions
Precision Biosciences Inc  4.25 $ 164.325  Millions$ 38.652  Millions
Greenlight Biosciences Holdings Pbc  4.18 $ 91.753  Millions$ 21.936  Millions
Outlook Therapeutics Inc   4.15 $ 43.536  Millions$ 10.488  Millions
Lineage Cell Therapeutics Inc   3.66 $ 42.755  Millions$ 11.684  Millions
Atara Biotherapeutics Inc   3.65 $ 237.123  Millions$ 64.960  Millions
Alector Inc   3.09 $ 565.327  Millions$ 183.015  Millions

Date modified: 2023-10-18T18:16:35+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com